Open Your Free Demat Account
Enjoy low brokerage on delivery trades
INDO-MIM Limited makes precision engineering components using metal injection moulding technology. The company was set up in 1996 and now runs 15 plants across India, the United States, the United Kingdom and Mexico. Its products serve the automotive, defence, medical, consumer and aerospace industries, and it ranked first globally by MIM revenue in CY2025 as per the industry report cited in the RHP.
The company reported revenue of ₹4,192.99 crore and profit after tax of ₹533.54 crore in FY2026. Revenue and profits have grown over the last three fiscals, and debt levels have come down. Its global rank, repeat customer base and dual-shore manufacturing are notable features of the business.
At the same time, the business depends heavily on exports, faces tariff-related risks in the US market, and works without long-term purchase commitments from customers. Investors may weigh these factors along with raw material costs, customer concentration and competition.
Precision engineering components sit inside many everyday and industrial products. Car safety systems, surgical tools, firearms and aircraft parts all rely on small metal parts made to exact measurements. One way to make such parts is metal injection moulding (MIM). According to the industry report cited in the Red Herring Prospectus (RHP), the global MIM market was estimated at US$ 4.0 billion in CY2025 and is projected to reach US$ 6.2 billion by CY2030.
INDO-MIM Limited has filed its Red Herring Prospectus with the Securities and Exchange Board of India (SEBI) for an initial public offering (IPO). The company makes precision engineering components using MIM technology. It also uses investment casting, precision machining, ceramic injection moulding and metal 3D printing.
For investors who want to understand the company's operations, financial performance, industry position and business risks, the RHP explains how the company earns revenue and how it plans to use the IPO proceeds. This article breaks down the key information from the RHP in a simple format.
The table below highlights the key details of the public issue as stated in the RHP.
Particulars | Details |
IPO Type | Book Built Offer |
Anchor Investor Bidding Date | Wednesday, 22 July 2026 |
IPO Open Date | Thursday, 23 July 2026 |
IPO Close Date | Monday, 27 July 2026 |
Face Value | ₹1 per equity share |
Price Band | ₹461 to ₹485 per share |
Lot Size | 30 shares |
Fresh Issue | Up to ₹500 crore |
Offer for Sale | Up to 6,82,91,022 equity shares |
Employee Reservation | Up to 2,00,000 equity shares |
Listing Exchange | NSE and BSE |
The IPO consists of both a Fresh Issue and an Offer for Sale (OFS).
Under the Fresh Issue portion, the company will receive funds of up to ₹500 crore. As per the RHP, ₹400 crore of this amount is planned for repayment or prepayment of certain outstanding borrowings. The balance will go towards general corporate purposes.
The OFS portion comprises up to 6,82,91,022 equity shares. The sellers include Green Meadows Investments Ltd, a corporate promoter, offering up to 6,05,24,322 shares. Anuradha Koduri, a promoter group shareholder, is offering up to 54,59,000 shares. The Indian Institute of Technology Madras, another selling shareholder, is offering up to 23,07,700 shares. The proceeds from the OFS will go to the selling shareholders and not to the company.
The RHP also sets aside up to 2,00,000 equity shares for eligible employees. Employees bidding in this portion may get a discount on the offer price, subject to approvals.
INDO-MIM Limited was incorporated on 12 April 1996 as A F Technologies India Private Limited in Hyderabad. The company changed its name more than once over the years before taking its present name in January 2024. Its registered and corporate office is in Hoskote, Bangalore, Karnataka.
The company's promoters are Green Meadows Investments Ltd, Krishna Chivukula, Krishna Chivukula Jr., Raj Chivukula and Jagadamba Chandrasekhar. Krishna Chivukula, the Chairman and Managing Director, has been with the company since incorporation and has over 30 years of experience in the MIM industry.
The company provides end-to-end solutions for making precision engineering components using MIM technology. Its work covers mould design and tooling, along with finishing and assembly. It made over 9,000 types of products in FY2026.
Its products serve five main groups:
Automotive: components for vehicle safety, fuel systems, powertrains and interiors
Defence: firearm components such as triggers, hammers and sights
Medical: components for surgical devices used in endoscopy, laparoscopy, dental robotics and orthopaedics
Consumer: parts for fashion accessories, cellphone components, tools and hardware
Aerospace: manifolds, precision housings, nozzles, locking rings and brackets for original equipment manufacturers (OEMs).
The company operates 15 manufacturing facilities. Six are in India, six in the United States, two in the United Kingdom and one in Mexico. This dual-shore model lets it serve customers who need local manufacturing as well as those who source globally. Its plants hold quality certifications including NADCAP, IATF 16949, AS 9100 and several ISO standards.
The company has also grown through acquisitions. It bought an investment casting business in the United States in FY2021, a MIM and 3D printing business in the United Kingdom, and a medical device design firm in the United States. It is also setting up a joint venture in India to make foldable hinge modules.
As of 31 March 2026, the company had 4,424 permanent employees in India, of which 4,100 were engineers, metallurgists, designers, toolmakers and technicians.
INDO-MIM earns revenue from the sale of precision components, along with powder, tools and traded products. It serves OEMs on a purchase order basis rather than through long-term supply commitments.
The company served more than 1,100 customers in FY2026. Repeat customers made up 91.60% of revenue from operations that year. Exports form the larger part of the business. Revenue from outside India was ₹3,236.97 crore in FY2026, or 77.20% of revenue from operations. North America alone accounted for 43.68% of revenue.
The revenue split by product group in FY2026 was: automotive 24.61%, defence 18.69%, medical 18.08%, aerospace 11.96%, consumer 10.80% and others 15.86%.
The company has three sales offices in China, Germany and the United States. It also has 13 sales representatives across countries such as France, Italy, Japan, South Korea and Singapore.
According to the industry report cited in the RHP, the company ranked first globally by revenue from MIM in CY2025, with a 6.8% market share. It has held this position for six years. As of 31 March 2026, it also had the highest installed capacity for MIM products worldwide, as per the same report.
MIM technology is used to make small, complex metal parts in large volumes. Demand comes from the automotive, defence, medical, consumer electronics and aerospace industries.
According to the industry report cited in the RHP:
The global MIM market was estimated at US$ 4.0 billion in CY2025 and is projected to reach US$ 6.2 billion by CY2030, a CAGR of 9.2%.
China accounted for about 53% of global MIM revenue in CY2025, followed by the USA at 18%, Europe at 13% and India at 12%.
The Indian MIM market is projected to grow at a CAGR of 10.3% between CY2025 and CY2030.
The North American MIM market is projected to rise from US$ 992 million in 2025 to US$ 1,612 million by 2030.
The report notes that the industry has high entry barriers. Setting up MIM plants needs large investment in equipment, moulds and inspection systems. Each new product also demands technical skill and long qualification timelines.
The company's numbers over the last three financial years show how its revenue, profits and balance sheet have moved. The table below presents key financial metrics as disclosed in the RHP. Figures have been converted from ₹ million to ₹ crore.
Financials (₹ crore) | FY2026 | FY2025 | FY2024 |
Total Income | 4,320.70 | 3,373.97 | 2,900.38 |
EBITDA | 1,070.92 | 932.60 | 743.46 |
PAT | 533.54 | 423.73 | 283.73 |
Total Assets | 4,897.33 | 4,140.84 | 3,757.51 |
Net Worth | 2,819.55 | 2,199.43 | 2,050.51 |
As per the industry research in RHP, MIM revenue ranking stood at the top globally with 6.8% share in CY2025 and this position has been maintained for six years. It has over 80 alloying choices and generates 45 to 50 new tools a month as at 31 March 2026.
Repeat customers contributed 91.60% of revenue from operations in FY2026. The industry report notes that OEMs in this segment rarely switch suppliers, which supports order continuity.
The company has 15 operations in India, the United States, the United Kingdom and Mexico and can serve customers seeking local supplies, as well as those looking for a worldwide source. Its capacity can shift between sectors as demand changes and its facilities are interchangeable.
Revenue comes from five product groups across automotive, defence, medical, consumer and aerospace applications. No single group contributed more than 25% of revenue in FY2026, which reduces reliance on any one sector.
Revenue from outside India formed 77.20% of revenue from operations in FY2026. A slowdown in global markets, currency moves or trade restrictions may affect demand.
The RHP notes that tariffs imposed by the US government, including higher import duties on Indian automotive components in August 2025, may raise costs and affect the price competitiveness of exports to the USA.
The company does business on a purchase order basis. Customers do not commit to fixed volumes and can change or cancel orders. This limits visibility on future demand.
The top 10 customers contributed 38.41% of revenue from operations in FY2026. Loss of any of these customers could affect results.
The company depends on metal powders and polymers sourced from domestic and international suppliers. Cost of materials consumed rose to 20.87% of revenue in FY2026 from 15.68% in FY2024. Supply gaps or price rises can affect margins.
The global MIM market has producers across China, the USA, Europe, Taiwan, Japan and India. Competition may affect pricing and market share.
Products for medical, defence and aerospace use must meet strict quality standards and certifications across several countries. Delays in securing approvals could affect operations.
Before evaluating the IPO, investors may consider the following factors:
The mix of Fresh Issue and Offer for Sale, and the planned use of ₹400.00 crore for debt repayment
The company's global rank and market share in MIM technology
Growth in revenue, EBITDA and PAT over the last three fiscals
High share of exports and exposure to trade policy changes
The purchase order-based business model and limited demand visibility
Diversification across automotive, defence, medical, consumer and aerospace sectors
Industry outlook for MIM and precision components
Risks linked to customer concentration, raw materials and competition
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading